Rosann Robinson

3.7k total citations
9 papers, 418 citations indexed

About

Rosann Robinson is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Rosann Robinson has authored 9 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Rosann Robinson's work include NF-κB Signaling Pathways (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Toxin Mechanisms and Immunotoxins (1 paper). Rosann Robinson is often cited by papers focused on NF-κB Signaling Pathways (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Toxin Mechanisms and Immunotoxins (1 paper). Rosann Robinson collaborates with scholars based in United States, Germany and Israel. Rosann Robinson's co-authors include Peter J. Waddell, Srividya Bhaskara, Carlo C. Maley, Joshua D. Schiffman, Shane T. Jensen, Kristy Lee, Ashley Chan, Michael S. Campbell, Lisa M. Abegglen and Aleah F. Caulin and has published in prestigious journals such as JAMA, PLoS ONE and Cancer Research.

In The Last Decade

Rosann Robinson

9 papers receiving 403 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Rosann Robinson 237 89 86 69 44 9 418
Ashley Chan 185 0.8× 81 0.9× 82 1.0× 65 0.9× 37 0.8× 6 385
Csaba Ortutay 502 2.1× 37 0.4× 102 1.2× 43 0.6× 147 3.3× 35 703
I. O. Petruseva 719 3.0× 120 1.3× 80 0.9× 93 1.3× 21 0.5× 47 799
Jeannine R. LaRocque 730 3.1× 141 1.6× 95 1.1× 107 1.6× 20 0.5× 26 866
Kelly LaMarco 409 1.7× 51 0.6× 151 1.8× 49 0.7× 154 3.5× 18 717
Stefania Francesconi 557 2.4× 63 0.7× 72 0.8× 57 0.8× 21 0.5× 26 698
Anuja Mehta 579 2.4× 90 1.0× 71 0.8× 118 1.7× 32 0.7× 5 676
Dylan Husmann 672 2.8× 45 0.5× 68 0.8× 34 0.5× 28 0.6× 7 818
Alissa M. Williams 448 1.9× 140 1.6× 110 1.3× 158 2.3× 37 0.8× 12 693

Countries citing papers authored by Rosann Robinson

Since Specialization
Citations

This map shows the geographic impact of Rosann Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosann Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosann Robinson more than expected).

Fields of papers citing papers by Rosann Robinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosann Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosann Robinson. The network helps show where Rosann Robinson may publish in the future.

Co-authorship network of co-authors of Rosann Robinson

This figure shows the co-authorship network connecting the top 25 collaborators of Rosann Robinson. A scholar is included among the top collaborators of Rosann Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosann Robinson. Rosann Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Bosse, Jens B., Orkide Ö. Koyuncu, Julian Scherer, et al.. (2021). Identification of African Elephant Polyomavirus in wild elephants and the creation of a vector expressing its viral tumor antigens to transform elephant primary cells. PLoS ONE. 16(2). e0244334–e0244334. 2 indexed citations
3.
Abegglen, Lisa M., Rosann Robinson, Mor Goldfeder, et al.. (2017). Abstract 2153: Elephant p53 (EP53) expression induces apoptosis of human cancer cells. Cancer Research. 77(13_Supplement). 2153–2153. 1 indexed citations
4.
Abegglen, Lisa M., Aleah F. Caulin, Ashley Chan, et al.. (2015). Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans. JAMA. 314(17). 1850–1850. 298 indexed citations
5.
Kim, Seho, Ashok C. Bajji, Rajendra Tangallapally, et al.. (2012). Discovery of (2S)-1-[4-(2-{6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9H-purin-9-yl}ethyl)piperidin-1-yl]-2-hydroxypropan-1-one (MPC-3100), a Purine-Based Hsp90 Inhibitor. Journal of Medicinal Chemistry. 55(17). 7480–7501. 36 indexed citations
6.
Lockman, Jeffrey W., Rosann Robinson, Patricia A. Ormonde, et al.. (2011). Oxindole derivatives as inhibitors of TAK1 kinase. Bioorganic & Medicinal Chemistry Letters. 21(6). 1724–1727. 24 indexed citations
7.
Fleischer, Tracey C., Vijay Baichwal, J. Jay Boniface, et al.. (2011). Abstract 3526: Coadministration of nicotinic acid with the Nampt inhibitor MPC-9528 enhances antitumor activity in Naprt deficient cancer cells in culture and in xenografts. Cancer Research. 71(8_Supplement). 3526–3526. 1 indexed citations
8.
Bursavich, Matthew G., J. Adam Willardsen, Zhong‐Hua Gao, et al.. (2010). 2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97). Bioorganic & Medicinal Chemistry Letters. 20(5). 1677–1679. 49 indexed citations
9.
Richards, Burt T., Vijay Baichwal, Ashley Chan, et al.. (2010). Cellular and In Vivo Properties of MPI‐0485520, a Novel and Potent Small Molecule Inhibitor of IKKe. The FASEB Journal. 24(S1). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026